Empowering mental health care specialists with a first-of-its-kind diagnostic device, our technology diagnose and distinguishes mental health disorders with precision, identifying at-risk individuals and guiding treatment.
We are dedicated to tackling the mental health crisis head-on. With our innovative diagnostic device, we empower mental health care specialists to provide precise diagnoses and tailored treatments to patients.
The actual experience and timeline can vary significantly for each individual based on factors such as the severity of symptoms, access to healthcare, social support, and individual response to treatment. Early recognition of symptoms and prompt intervention can improve outcomes.
Individual costs touch on every aspect related to one’s quality of life, from loss of productivity, autonomy, finances, and time.
The overlap between individual costs and societal costs when a person experiences mental health issues is significant and multifaceted.
The psychosis diagnostics market is on a robust growth trajectory, evidenced by a jump from US$ 2.04 Billion in 2022 to a projected US$ 3.6 Billion by 2033, expanding at a CAGR of 5.3%.